Cephalexin For Cats Dosage Calculator
Calculate accurate cephalexin dosage for cats by weight, infection severity, and formulation. Covers tablets, capsules, and oral suspension.
About
Cephalexin (cefalexin) is a first-generation cephalosporin antibiotic prescribed for feline bacterial infections including skin and soft tissue wounds, urinary tract infections, and bone infections. The standard therapeutic range is 10 - 25 mg/kg administered every 8 - 12 hours, but dosing errors are common because commercial formulations vary in concentration (25 mg/mL, 50 mg/mL, 100 mg/mL suspensions; 250 and 500 mg capsules). Underdosing promotes antimicrobial resistance. Overdosing increases the risk of gastrointestinal adverse effects (vomiting, diarrhea) and, in rare cases, nephrotoxicity. This calculator applies weight-based dosing per Plumb's Veterinary Drug Handbook and rounds liquid volumes to 0.1 mL precision suitable for oral syringes.
Note: this tool approximates dosing for otherwise healthy adult cats. Neonatal kittens, cats with renal insufficiency (GFR < 30 mL/min), or cats on concurrent nephrotoxic drugs require veterinary adjustment. Cephalexin is not effective against Pseudomonas spp. or anaerobes. Always confirm culture and sensitivity results before prolonged therapy.
Formulas
The per-dose amount of cephalexin is calculated from the cat's body weight and the selected dose rate:
Where D = single dose (mg), W = body weight (kg), and R = dose rate (mg/kg).
For oral suspension, the volume per dose is:
Where V = volume per dose (mL) and C = suspension concentration (mg/mL).
For tablets or capsules, the number of units per dose is:
Where S = tablet/capsule strength (mg). Weight conversion when input is in pounds: Wkg = Wlb Γ 0.453592. Total supply over the treatment course: T = Ndoses/day Γ days.
Reference Data
| Infection Type | Dose Range | Frequency | Typical Duration | Notes |
|---|---|---|---|---|
| Skin & soft tissue (mild) | 10 - 15 mg/kg | q12h | 7 - 14 days | Superficial pyoderma, small abscesses |
| Skin & soft tissue (moderate) | 15 - 22 mg/kg | q8 - 12h | 14 - 21 days | Deep pyoderma, bite wounds |
| Skin & soft tissue (severe) | 22 - 30 mg/kg | q8h | 21 - 28 days | Cellulitis, surgical site infections |
| Urinary tract infection (uncomplicated) | 10 - 15 mg/kg | q8 - 12h | 10 - 14 days | Confirm gram-positive susceptibility |
| Urinary tract infection (complicated) | 15 - 25 mg/kg | q8h | 14 - 28 days | Recurrent UTI; culture guided |
| Bone & joint infection | 22 - 30 mg/kg | q8h | 28 - 42 days | Osteomyelitis; long-term therapy |
| Respiratory (upper, mild) | 10 - 15 mg/kg | q12h | 7 - 10 days | Secondary bacterial rhinitis |
| Respiratory (lower) | 15 - 25 mg/kg | q8h | 14 - 21 days | Bacterial pneumonia |
| Dental prophylaxis | 22 mg/kg | q12h | 5 - 7 days | Perioperative; start 24h pre-op |
| Post-surgical prophylaxis | 15 - 22 mg/kg | q8 - 12h | 5 - 10 days | Clean-contaminated wounds |
| Otitis media | 15 - 25 mg/kg | q8h | 14 - 21 days | If gram-positive confirmed |
| Wound infection (fight abscess) | 15 - 22 mg/kg | q8h | 10 - 14 days | Drain if fluctuant; consider anaerobic cover |
| Staphylococcal folliculitis | 22 - 25 mg/kg | q8h | 21 - 28 days | Continue 7 days past clinical resolution |